IMU 2.08% 4.9¢ imugene limited

Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx, page-32

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 221 Posts.
    lightbulb Created with Sketch. 2
    I'm a happy holder, however I would like to know, How many patients were in the initial study? Apart from the patient that the tumor was reduced to zero what happened with the others on the Phase 1 trial?
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
4.9¢
Change
0.001(2.08%)
Mkt cap ! $364.4M
Open High Low Value Volume
4.8¢ 5.0¢ 4.8¢ $458.6K 9.378M

Buyers (Bids)

No. Vol. Price($)
6 1039220 4.9¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 5436876 20
View Market Depth
Last trade - 16.10pm 07/10/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.